Borregaard ASA (OSL:BRG)

Revenue

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BioSolutions Revenue	4.25B	4.40B	4.24B
BioMaterials Revenue	2.89B	2.69B	2.62B
Fine Chemicals Revenue	746.00M	670.00M	799.00M
Eliminations From Revenue	-42.00M	-44.00M	-45.00M
Revenue (Total)	7.85B	7.71B	7.62B

Revenue by Geography

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
Norway Revenue	-	328.00M	227.00M
Rest of Europe Revenue	-	3.12B	3.25B
Asia Revenue	-	1.89B	1.72B
America Revenue	-	2.17B	2.24B
Rest of World Revenue	-	77.00M	60.00M
Other Operating Revenue	-	133.00M	115.00M
Revenue (Total)	7.85B	7.71B	7.62B

EBITDA

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BioSolutions EBITDA	1.10B	1.21B	1.10B
BioMaterials EBITDA	590.00M	495.00M	434.00M
Fine Chemicals EBITDA	220.00M	174.00M	336.00M
Operating Income (Other)	-635.00M	-591.00M	-591.00M
Operating Income (Total)	1.27B	1.29B	1.28B

EBIT

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BioSolutions Operating Profit	777.00M	896.00M	791.00M
BioMaterials Operating Profit	325.00M	263.00M	200.00M
Fine Chemicals Operating Profit	168.00M	128.00M	292.00M
Operating Income (Total)	1.27B	1.29B	1.28B

Key Performance Indicators

Financials in millions NOK. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
BioSolutions - Gross Average Sales Price per MTDS	12.03K	12.05K
BioSolutions - Specialties Sales Volume (MTDS in Thousands)	91.00	85.00
BioSolutions - Construction Sales Volume (MTDS in Thousands)	97.00	97.00
BioSolutions - Industrial Sales Volume (MTDS in Thousands)	142.00	145.00
BioSolutions - Total Sales Volume (MTDS in Thousands)	330.00	327.00
BioMaterials - Gross Average Sales Price per MT	17.68K	16.34K
BioMaterials - Sales Volume (MT in Thousands)	146.40	159.90
High Specialised % of Total Cellulose Product Sales Volume	87.00%	83.00%

Data Source: Fiscal.ai Last updated: Oct 27, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error